A verapamil és bisoprolol összehasonlító vizsgálata szívinfarktuson átesett betegek szekunder prevenciójában.

Translated title of the contribution: Comparative study of verapamil and bisoprolol in the secondary prevention of myocardial infarction

I. Sárosi, G. Debreceni, D. Mühl, A. Kónyi, L. Bogár, M. Tekeres, K. Tóth, T. Habon, L. Czopf, K. Zámbó, E. Schmidt

Research output: Contribution to journalReview article

Abstract

The effect of Ca-antagonist, long-acting verapamil and the selective beta-1 blocking bisoprolol were investigated and compared in the secondary prevention after myocardial infarction. Eighty-seven patients were enrolled, 27 patients were not included because of the exclusion criteria, 30 patients were treated with verapamil and 30 patients with bisoprolol. During the 540 days of follow up period treadmill ergometry and dobutamine stress-test with SPECT investigation were performed two times. Both clinically and the data of our investigations the effect of the two drugs in the secondary prevention was good, and even at the 540th day the protective effect was still excellent.

Translated title of the contributionComparative study of verapamil and bisoprolol in the secondary prevention of myocardial infarction
Original languageHungarian
Pages (from-to)1939-1945
Number of pages7
JournalOrvosi hetilap
Volume138
Issue number31
Publication statusPublished - Aug 3 1997

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Comparative study of verapamil and bisoprolol in the secondary prevention of myocardial infarction'. Together they form a unique fingerprint.

  • Cite this

    Sárosi, I., Debreceni, G., Mühl, D., Kónyi, A., Bogár, L., Tekeres, M., Tóth, K., Habon, T., Czopf, L., Zámbó, K., & Schmidt, E. (1997). A verapamil és bisoprolol összehasonlító vizsgálata szívinfarktuson átesett betegek szekunder prevenciójában. Orvosi hetilap, 138(31), 1939-1945.